Show simple item record

dc.contributor.authorPan American Health Organization
dc.date.accessioned2020-09-21T19:34:34Z
dc.date.available2020-09-21T19:34:34Z
dc.date.issued2020-07-16
dc.identifier.urihttps://hdl.handle.net/20.500.12663/2187
dc.description.abstractPAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.
dc.languageEnglish
dc.subjectInfecctious Diseases
dc.subjectCOVID-19
dc.subjectCoronavirus
dc.titlePAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
eihealth.countryRegional, Americas (PAHO/OPS)
eihealth.categoryInfection prevention and control, including health care workers protection
eihealth.typeWHO/PAHO Guidance
eihealth.maincategorySlow Spread / Reducir la Dispersión


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record